Wegovy maker Novo Nordisk struck a deal to buy heart-disease-therapeutics developer Cardior Pharmaceuticals for up to the equivalent of $1.11 billion

Wegovy maker Novo Nordisk struck a deal to buy heart-disease-therapeutics developer Cardior Pharmaceuticals for up to the equivalent of $1.11 billion.#novonordisk
Source: Reuters: Health - Category: Consumer Health News Source Type: news